Description:
Cybin Inc. is a biotechnology company focused on psychedelic-based therapeutics, aiming to enhance mental health treatment with innovative drug development. The company is leveraging its proprietary platforms to develop novel compounds and delivery methods for treatments targeting conditions such as depression and anxiety. With a strong emphasis on conducting rigorous clinical trials, Cybin is positioned at the forefront of the rapidly evolving psychedelic medicine sector, offering potential solutions for unmet medical needs. Its strategic partnerships and research initiatives underline a commitment to advancing the scientific understanding and therapeutic applications of psychedelics in mental health care.
Address:
100 KING STREET WEST, TORONTO, ON, CANADA, M5X 1C9
Market capitalization:
$413 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
6 years:
+10%
How much will you get:
$1,099
Prices dates:
13-09-2019: $7.44 and 31-12-2025: $8.18